Clinical trial of drug wesnil plus to see its safety and efficacy in alcohol deaddiction treatment
Phase 2
- Conditions
- Health Condition 1: F102- Alcohol dependence
- Registration Number
- CTRI/2022/09/045406
- Lead Sponsor
- Shree Saptshrungi Nivasini Ayurvedic Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Chronic alcohol drinking history more than 3 years.
Alcohol withdrawal patients, including vomiting, nausea, tremors, anxiety, agitation etc. that had presented at that time.
Exclusion Criteria
Nervous, Cardio, Vascular, Renal, Metabolic, etc.
- patients with h/o haematemisis, active PR bleeding and hoemorrhoids
- Patient who has clinical history of sensitivity of ingredients contains in
Wesnil Plus.
- Patient suffering from uncontrolled DM, HTN , Acute coronary Artery
diseases, Asthma & any other major illness.
- Patients on antitubercular and antiretroviral treatment.
- Patient whose heart, liver or kidney function is seriously abnormal.
- Patient who has participated in other clinical trial within
two months before starting these trials.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean reduction (Mean �± SD) in desire and frequency of alcohol consumption.Timepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method Global assessment score for the accessibility of Wesnil Plus. <br/ ><br> <br/ ><br>Timepoint: 4 weeks